Facet Biotech News

During the past week, GuruFocus recognized four companies as dividend growers. In order to be considered for this list, the company had to: A Have a dividend yield of more than 3%.

Abbott Laboratories seems to think its stock is cheap enough to justify sinking a substantial amount of its nest egg into the company's stock.

The company develops and sells nutritional, medical, diagnostic equipments and other products.

This afternoon, Abbott Laboratories declared its quarterly dividend of 14 cents per share, maintaining the amount paid to shareholders the last quarter.

PI SCOOPLET ... MORRIS EXITING ABBOTT: Kristin Morris , divisional vice president of federal government affairs at Abbott Laboratories , is leaving for a new job.

ATRS ) 's transformational product , I have been inundated with reader requests to conduct a valuation study on another drug-device combination currently being advanced into QS-T is being developed to administer testosterone using a subcutaneous injection route by patients themselves, essentially eliminating the need to receive the doctor's office.

As populations grow and as food safety concerns increase, parents are being very selective about the infant baby formulas they buy.

In the first quarter of 2013 Abbott Laboratories' sales of medical devices fell 4.6% to $1.33 billion, with revenue from stents and related vascular products down almost 8% to $742 million due largely to price pressures in the United States.

Sagent Advisors, LLC, a leading independent investment banking firm, announced today that Jeremy Parker has joined the firm as Managing Director, effective immediately.

An archived edition of the presentation will be available later that day. Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare.

Abbott Laboratories aggressively promoted its Niaspan cholesterol treatment, almost tripling U.S. use of the medication, in the seven-year period before studies in 2011 found the drug ineffective, a study found.

The company is principally engaged in providing blood screening tests for the in-vitro diagnostic markets.

Abbott Laboratories is one of the major players in the American healthcare sector.

Attorney General Kenneth T. Cuccinelli II said Wednesday that the Internal Revenue Service is blocking the release of $125 million owed to Virginia from a Medicaid fraud settlement.

Prior to co-founding Capstone, Kearns was a senior managing director at the Policano & Manzo legacy practice of FTI Consulting and a predecessor firm from 1991 to 2004.

A live audio webcast of the presentation will be accessible through Abbott's Investor Relations Web site at www.abbottinvestor.com .

AstraZeneca Plc will take a $140 million charge after deciding to halt development of an experimental rheumatoid arthritis treatment that showed mixed results in late-stage studies.

He was a visionary leader, a devoted father to his children, and a good friend. The company's directors and employees, as well as many of the people he worked with and mentored over the years, mourn his loss.

There are three types of biotech stocks to buy that generally fall into one of these typically non-overlapping groups: Value investing isn't usually associated with biotech stocks to buy; if anything, biotech investors are notorious for being overly optimistic.

's stock had its "buy" rating restated by research analysts at Jefferies Group in a report released on Tuesday, Analyst Ratings Network.com reports.